100 related articles for article (PubMed ID: 1349527)
1. Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis.
Weller AH; Hall M; Huber SA
Eur Heart J; 1992 Jan; 13(1):115-9. PubMed ID: 1349527
[TBL] [Abstract][Full Text] [Related]
2. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.
Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J
Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
Zhang H; Yousef GE; Ouyang X; Archard LC
Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
[TBL] [Abstract][Full Text] [Related]
4. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
Job LP; Lyden DC; Huber SA
Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
8. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
9. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.
Huber SA
Med Microbiol Immunol; 2005 May; 194(3):121-7. PubMed ID: 15107990
[TBL] [Abstract][Full Text] [Related]
10. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.
Huber SA; Sartini D; Exley M
J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility.
Huber SA; Rincon M
Virology; 2008 Nov; 381(2):155-60. PubMed ID: 18829062
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice.
Blay R; Simpson K; Leslie K; Huber S
Am J Pathol; 1989 Nov; 135(5):899-907. PubMed ID: 2573284
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
15. T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis.
Huber SA; Moraska A; Choate M
J Virol; 1992 Nov; 66(11):6541-6. PubMed ID: 1328680
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
Lodge PA; Herzum M; Olszewski J; Huber SA
Am J Pathol; 1987 Sep; 128(3):455-63. PubMed ID: 2957924
[TBL] [Abstract][Full Text] [Related]
17. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
18. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
Yin L; Chai D; Yue Y; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
[TBL] [Abstract][Full Text] [Related]
19. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
20. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]